KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Notes Payables: 2020

  • Ginkgo Bioworks Holdings' Notes Payables was N/A to $300,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $300,000, marking a year-over-year change of. This contributed to the annual value of $300,000 for FY2020, which is N/A change from last year.
  • According to the latest figures from Q4 2020, Ginkgo Bioworks Holdings' Notes Payables is $300,000.
  • Ginkgo Bioworks Holdings' 5-year Notes Payables high stood at $300,000 for Q4 2020, and its period low was $300,000 during Q4 2020.
  • For the 1-year period, Ginkgo Bioworks Holdings' Notes Payables averaged around $300,000, with its median value being $300,000 (2020).